Harvey Cantor Selected Research

Harvey Cantor Research Topics

Disease

12	Neoplasms (Cancer) 01/2022 - 03/2009
8	Infections 01/2021 - 01/2002
8	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 04/2004
5	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2011 - 03/2002
3	Brain Injuries (Brain Injury) 01/2018 - 09/2014
3	Virus Diseases (Viral Diseases) 07/2017 - 12/2013
2	Neuroinflammatory Diseases 09/2023 - 01/2022
2	Alzheimer Disease (Alzheimer's Disease) 09/2023 - 01/2023
2	Inflammation (Inflammations) 12/2013 - 08/2004
2	Arthritis (Polyarthritis) 03/2013 - 08/2004
2	Disease Progression 03/2013 - 08/2011
2	Rheumatoid Arthritis 03/2013 - 08/2004
2	Multiple Sclerosis 01/2013 - 01/2011
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 09/2023
1	Cognitive Dysfunction 09/2023
1	Hyperglycemia 01/2020
1	Persistent Infection 07/2017
1	Latent Tuberculosis 05/2017
1	Atherosclerosis 02/2015
1	Communicable Diseases (Infectious Diseases) 01/2015
1	Experimental Melanoma 03/2014
1	Experimental Arthritis 03/2013
1	Colitis 01/2013
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2013
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 10/2011
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 09/2010
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 03/2009
1	Human Influenza (Influenza) 01/2008
1	Lung Injury 01/2008
1	Pneumonia (Pneumonitis) 01/2008
1	Osteitis 08/2004
1	Hyperplasia 08/2004
1	Hypersensitivity (Allergy) 10/2002

Drug/Important Bio-Agent (IBA)

9	Peptides (Polypeptides)IBA 05/2017 - 07/2002
8	OsteopontinIBA 09/2023 - 03/2002
6	Proteins (Proteins, Gene)FDA Link 09/2023 - 07/2002
6	CytokinesIBA 01/2022 - 07/2002
5	AntigensIBA 01/2021 - 05/2007
3	Messenger RNA (mRNA)IBA 01/2018 - 08/2004
3	Transcription Factors (Transcription Factor)IBA 01/2018 - 09/2014
3	Interferon Type IIBA 11/2017 - 07/2008
3	AutoantibodiesIBA 03/2014 - 08/2004
2	AntibodiesIBA 01/2020 - 08/2004
2	Glycoproteins (Glycoprotein)IBA 01/2020 - 08/2004
2	AutoantigensIBA 01/2018 - 01/2011
2	MicroRNAs (MicroRNA)IBA 07/2017 - 01/2017
2	Antiviral Agents (Antivirals)IBA 12/2013 - 01/2008
1	IntegrinsIBA 09/2023
1	Interleukin-23 (Interleukin 23)IBA 01/2022
1	InterferonsIBA 01/2022
1	Interleukin-12 (IL 12)IBA 01/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022
1	Polycomb Repressive Complex 2IBA 10/2020
1	Enhancer of Zeste Homolog 2 ProteinIBA 10/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2018
1	Interleukin-22 (IL-22)IBA 01/2018
1	AerosolsIBA 05/2017
1	AntioxidantsIBA 01/2017
1	C-Type Lectins (C-Type Lectin)IBA 12/2015
1	ApolipoproteinsIBA 02/2015
1	Interleukin-15 (Interleukin 15)IBA 01/2015
1	Thrombin FDA Link 12/2014
1	Neuroprotective AgentsIBA 12/2014
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 03/2014
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2013
1	Methotrexate (Mexate)FDA LinkGeneric 03/2013
1	Glatiramer Acetate (Copaxone)FDA Link 01/2013
1	Dextran SulfateIBA 01/2013
1	Therapeutic UsesIBA 01/2013
1	ChromatinIBA 10/2011
1	NK Cell Lectin-Like Receptor Subfamily CIBA 08/2011
1	Immunodominant EpitopesIBA 01/2011
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2009
1	LigandsIBA 01/2008
1	Tartrate-Resistant Acid PhosphataseIBA 08/2004
1	Hematoxylin (Haematoxylon)IBA 08/2004
1	Collagen Type II (Type II Collagen)IBA 08/2004
1	Eosine Yellowish-(YS) (Eosin)IBA 08/2004
1	Tolonium Chloride FDA Link 08/2004
1	PhosphoproteinsIBA 10/2002
1	EpitopesIBA 01/2002

Therapy/Procedure

6	Immunotherapy 01/2022 - 03/2014
3	Therapeutics 03/2013 - 04/2004
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 03/2009
1	Ligation 01/2008
1	Transplantation 05/2007